Release Date: 22/11/13 16:12 Summary: Notice of completion of sending Bidder's Statement Price Sensitive: No Download Document 1.67MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%